Niagen Bioscience (NAGE) Other Working Capital Changes (2011 - 2026)
Niagen Bioscience (NAGE) reported Other Working Capital Changes of -$13000.0 for Q1 2026, up 35.0% year-over-year from -$9629.6 in Q1 2025, and up 97.74% quarter-over-quarter from -$574000.0 in Q4 2025.
Niagen Bioscience (NAGE) Other Working Capital Changes (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 14 years of Other Working Capital Changes data on file, last reported at -$13000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$13000.0, up 35.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$942000.0 (down 819.08% YoY), and the FY2025 annual result was -$949000.0, down 2208.89% from the prior year.
- Other Working Capital Changes grew to -$13000.0 in Q1 2026 per NAGE's latest filing, from -$574000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.2 million in Q3 2022 and troughed at -$2.7 million in Q4 2022.
- A 5-year average of -$119058.8 and a median of -$138000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes jumped 845.85% in 2022, then sank 350.91% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at -$2.7 million in 2022, then soared by 93.02% to -$190000.0 in 2023, then jumped by 508.95% to $777000.0 in 2024, then plunged by 173.87% to -$574000.0 in 2025, then surged by 97.74% to -$13000.0 in 2026.
- Business Quant data shows NAGE's Other Working Capital Changes at -$13000.0 in Q1 2026, -$574000.0 in Q4 2025, and -$87000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,000.00 |
| Mar 31, 2026 | -13,000.00 |
| Dec 31, 2025 | -574,000.00 |
| Dec 31, 2025 | -574,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Jun 30, 2025 | -268,000.00 |
| Jun 30, 2025 | -268,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Dec 31, 2024 | 777,000.00 |
| Dec 31, 2024 | 777,000.00 |
| Sep 30, 2024 | -411,000.00 |
| Sep 30, 2024 | -411,000.00 |
| Jun 30, 2024 | -215,000.00 |
| Jun 30, 2024 | -215,000.00 |
| Mar 31, 2024 | -106,000.00 |
| Mar 31, 2024 | -106,000.00 |
| Dec 31, 2023 | -190,000.00 |
| Dec 31, 2023 | -190,000.00 |